• 1
    Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 5770.
  • 2
    Lands SH, Murray T, Bolden S. Cancer statistics. Ca Cancer J Clin 1998; 48: 629.
  • 3
    Estimated new cancer cases and death by sex for all sites. United States: American Cancer Society, 2000.
  • 4
    Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Path Microbiol Scand 1965; 64: 3149.
  • 5
    Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998; 396(6712): 6439.
  • 6
    Perucho M. Cancer of the microsatellite mutator phenotype. Biol Chem 1996; 377(11): 67584.
  • 7
    Buermeyer AB, Deschenes SM, Baker SM, Liskay RM. Mammalian DNA mismatch repair. Annu Rev Genet 1999; 33: 53364.
  • 8
    Tahara E. Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol 1993; 119: 26572.
  • 9
    Sepulveda AR. Molecular testing of Helicobacter pylori-associated chronic gastritis and premalignant gastric lesions: clinical implications. J Clin Gastroenterol 2001; 32: 37782.
  • 10
    Heyden JD, Martin IG, Cawkwell L. The role of microsatellite instability in gastric carcinome. Gut 1998; 42: 3003.
  • 11
    Semba S, Yokozaki H, Yamamoto S, Yasui W, Tahara E. Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach. Cancer 1996; 77: 16207.
  • 12
    Bearzatto A, Szadkowski M, Macpherson P, et al. Epigenetic regulation of the MGMT and hMSH6 DNA repair genes in cells resistant to methylating agents. Cancer Res 2000; 60: 326270.
  • 13
    Ottini L, Palli D, Falchetti M, et al. Microsatellite instability in gastric cancer is associated with tumor location and family history in a high risk population from Tuscany. Cancer Res 1997; 57: 45239.
  • 14
    Eshleman JR, Markowitz SD. Microsatellite instability in inherited and sporadic neoplasms. Curr Opin Oncol 1995; 7: 839.
  • 15
    Rocco A, Staibano S, Ottini L, et al. Is there a link between environmental factors and genetic predisposition to cancer? A lesson from a familial cluster of gastric cancer. Eur J Cancer 2003; in press.
  • 16
    Weissenbach J, Gyapay G, Dib C, et al. Linkage map of the human genome. Nature 1992; 359: 794801.
  • 17
    Werner M, Becker KF, Keller G, Hofler H. Gastric adenocarcinoma: pathomorphology and molecular pathology. J Cancer Res Clin Oncol 2001; 127: 207216.
  • 18
    Moss SF. Review article: cellular markers in the gastric precancerous process. Aliment Pharmacol Ther 1998; 12(Suppl. 1): 91109.
  • 19
    Correa P, Shiao YH. Phenotypic and genotypic events in gastric carcinogenesis. Cancer Res 1994; 54(Suppl.): 19413.
  • 20
    Morgan D. Principles of cdk regulation. Nature 1995; 374: 1314.
  • 21
    Nielsen GP, Stemmer-Rachamimov AO, Shaw J, Roy JE, Koh J, Louis DN. Immunohistochemical survey of p16INK4A expression in normal human adult and infant tissues. Lab Inv 1999; 79: 113743.
  • 22
    Sard L, Accornero P, Tornielli S, et al. The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control. Proc Natl Acad Sci USA 1999; 96: 848992.
  • 23
    Rocco A, Schandl L, Nardone G, et al. Loss of expression of tumor suppressor p16INK4protein in human primary gastric cancer is related to the grade of differentiation. Dig Dis 2002; 20: 1025.
  • 24
    Raff M. Cell suicide for beginners. Nature 1998; 396: 11922.
  • 25
    Ayhan A, Yasui W, Yokozaki H, Seto M, Ueda R, Tahara E. Loss of heterozygosity at the bcl-2 gene locus and expression of bcl-2 in human gastric and colorectal carcinomas. Jpn J Cancer Res 1994; 85: 58491.
  • 26
    Klein RF, Vollmers HP, Muller-Hermelink HK. Different expression of bcl-2 in diffuse and intestinal type stomach carcinoma. Oncol Rep 1994; 69: 9436.
  • 27
    Vollemers HP, Dammrich J, Hensel F, et al. Differential expression of apoptosis receptors on diffuse and intestinal type stomach carcinoma. Cancer 1997; 79: 43340.
  • 28
    Vollemers HP, Zimmermann U, Krenn V, et al. Adjuvant therapy for gastric adenocarcinoma with the apoptosis-inducing human monoclonal antibody SC-1: first clinical and histopathological results. Oncol Rep 1998; 5: 54952.
  • 29
    Ranzani GN, Luinetti O, Padovan LS, et al. Gene mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type. Cancer Epidemiol Biomarkers Prev 1995; 4: 22331.
  • 30
    Tahara E. Genetic alterations in human gastrointestinal cancers. Cancers 1995; 75: 14107.
  • 31
    Sano T, Tsujino T, Yoshida K, et al. Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas. Cancer Res 1991; 51: 292631.
  • 32
    Gong G, Mera R, Bravo JC, et al. KRAS mutations predict progression of preneoplastic gastric lesions. Cancer Epidemiol Biomarkers Prev 1999; 8: 16771.
  • 33
    Kihana T, Tsuda H, Hirota T, et al. Point mutation of c-Ki-ras oncogene in gastric adenoma and adenocarcinoma with tubular differentiation. Jpn J Cancer Res 1991; 82: 30814.
  • 34
    Park WS, Oh RR, Park JY, et al. Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer. Cancer Res 1999; 59: 425760.
  • 35
    Candidus S, Bischoff P, Becker KF, Hofler H. No evidence for mutations in alpha and beta-catenin genes in human gastric and breast carcinomas. Cancer Res 1996; 56: 4952.
  • 36
    Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991; 251: 14517.
  • 37
    Gayter SA, Gorringe KL, Ramus SJ, et al. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res 1998; 58: 40869.
  • 38
    Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 26(392): 4025.
  • 39
    Caldas C, Carneiro F, Linch HT, et al. Familial gastric cancer: overview and guidelines for management. J Med Genet 1999; 36: 87380.
  • 40
    Uchino S, Tsuda H, Maruyama K, et al. Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients. Cancer 1993; 72: 317984.
  • 41
    Yonemura Y, Ninomiya I, Yamaguchi A, et al. Evaluation of immunoreactivity for erB-2 protein as a marker of poor short-term prognosis in gastric cancer. Cancer Res 1991; 51: 10348.
  • 42
    Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995; 19: 3743(S).
  • 43
    Goldstone AR, Quirke P, Dixon MF. Helicobacter pylori infection and gastric cancer. J Pathol 1996; 179: 12937.
  • 44
    Huang JQ, Sridar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998; 114: 116979.
  • 45
    Forman D, Newell DG, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from prospective investigation. Br Med J 1991; 302: 13025.
  • 46
    Parsonnet J, Friedman GD, Oremtreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997; 40: 297301.
  • 47
    Nomura A, Stemmermann GN, Chyou PH, Kato J, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325: 11326.
  • 48
    The Eurogast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341: 135962.
  • 49
    Watanabe T, Tada M, Nagai H, et al. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology 1998; 115: 6428.
  • 50
    Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res 1998; 58: 42559.
  • 51
    Miwa M, Stuehr DJ, Marletta MA, et al. Nitrosation of amines by stimulated macrophages. Carcinogenesis 1987; 8: 9558.
  • 52
    Kosaka H, Tsuda M, Kurashima Y, et al. Marked nitrosation by stimulation with lipopolysaccharide in ascorbic acid deficient rats. Carcinogenesis 1990; 11: 18879.
  • 53
    Wink DA, Kazimierz S, Maragos CN, et al. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991; 254: 10013.
  • 54
    Nardone G, Staibano S, Rocco A, et al. The effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis. Gut 1999; 44: 78999.
  • 55
    Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 7849.
  • 56
    El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404(6776): 398402.
  • 57
    Azuma T, Ito S, Sato F, et al. The role of the HLA-DQA1 gene in resistance to atrophic gastritis and gastric adenocarcinoma induced by Helicobacter pylori infection. Cancer 1998; 82: 10138.